deltatrials
Completed OBSERVATIONAL NCT03603366

Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum

Patient-centred Benefit-risk Observational Study of Low-dose Aspirin for CVD (Cardiovascular Disease) and CRC (Colorectal Cancer) Prevention

Sponsor: Bayer

Conditions Cardiovascular Disease Colorectal Cancer
Interventions Acetylsalicylic acid (Aspirin, BAYE4465)
Updated 21 times since 2018 Last updated: Sep 30, 2020 Started: Aug 14, 2019 Primary completion: Oct 14, 2019 Completion: Oct 14, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cardiovascular Disease and Colorectal Cancer and is currently completed. Bayer leads this study, which shows 21 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Oct 2020 · 10 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

21 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Oct 2020 — Jan 2021 [monthly]

    Completed

  5. Dec 2019 — Oct 2020 [monthly]

    Completed

    Status: Recruiting → Completed

▶ Show 16 earlier versions

  1. Nov 2019 — Dec 2019 [monthly]

    Recruiting

  2. Oct 2019 — Nov 2019 [monthly]

    Recruiting

  3. Sep 2019 — Oct 2019 [monthly]

    Recruiting

  4. Aug 2019 — Sep 2019 [monthly]

    Recruiting

  5. Jul 2019 — Aug 2019 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  6. Jun 2019 — Jul 2019 [monthly]

    Not Yet Recruiting

  7. May 2019 — Jun 2019 [monthly]

    Not Yet Recruiting

  8. Apr 2019 — May 2019 [monthly]

    Not Yet Recruiting

  9. Mar 2019 — Apr 2019 [monthly]

    Not Yet Recruiting

  10. Feb 2019 — Mar 2019 [monthly]

    Not Yet Recruiting

  11. Jan 2019 — Feb 2019 [monthly]

    Not Yet Recruiting

  12. Dec 2018 — Jan 2019 [monthly]

    Not Yet Recruiting

  13. Nov 2018 — Dec 2018 [monthly]

    Not Yet Recruiting

  14. Oct 2018 — Nov 2018 [monthly]

    Not Yet Recruiting

  15. Sep 2018 — Oct 2018 [monthly]

    Not Yet Recruiting

  16. Aug 2018 — Sep 2018 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bayer
Data source: Bayer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations